Palliser Capital urges Recordati's board to withdraw support for CVC-GBL offer

By Reuters News

- Activist investor Palliser Capital said on Monday it had urged Recordati's RECI.MI board to withdraw support for a €51.29 per share takeover offer from CVC Capital Partners and Belgian investment group Groupe Bruxelles Lambert GBLB.BR, arguing it materially undervalues the Italian drugmaker.

  • Palliser, which sent a letter to the board on September 1, said the consortium should raise its offer to at least €60 per share to provide fair treatment for minority investors.

  • Private equity firm CVC and GBL in May launched an all-cash offer for Recordati through the Respighi BidCo vehicle, valuing the company at about €10.7 billion ($12.35 billion) and aiming to delist it from the Milan stock exchange.

  • The offer has split Recordati's 10-member board, with six voting in favour of the offer, while four independent directors deemed it inadequate. Palliser noted that the offer was not endorsed by any independent directors.

  • CVC currently holds a majority stake in a vehicle called Rossini which controls a 46.8% interest in Recordati.

  • Palliser also said the deal structure put undue pressure on minority shareholders to tender, potentially leaving those who do not participate with illiquid, delisted stock.

  • Recordati's shares were trading 0.5% higher at €52.25 at 0820 GMT.

  • The tender offer opened on August 31 and is due to close on October 15.

  • Six minority shareholders, including several long-only investors, told the FT on Sunday they opposed the terms of the offer.

  • Respighi and Recordati did not immediately respond to a request for comment.

  • Respighi said in July that it disagreed with the independent directors' assessment, reiterated that the offer was fair and attractive, and said its terms and conditions were unchanged.

($1 = 0.8666 euros)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.